A Moran Eye Center age-related macular degeneration (AMD) patient recently became the first in Utah to test a new gene therapy developed by the Sharon Eccles Steele Center for Translational...
Patient testing is underway for a new therapy for age-related macular degeneration (AMD) developed by the John A. Moran Eye Center’s Sharon Eccles Steele Center for Translational Medicine (SCTM).
A 78-year-old man was referred for an ultrasound of his right eye to evaluate a small choroidal nevus. He also mentioned almost total loss of vision in his left eye...
